Biomarkers of neoadjuvant/adjuvant chemotherapy for breast cancer.
Iwamoto T, Kajiwara Y, Zhu Y, Iha S.
Chin Clin Oncol. 2020 Jun;9(3):27. doi: 10.21037/cco.2020.01.06. Epub 2020 Mar 13.
Pancreatic cancer treatment: better, but a long way to go.
Torphy RJ, Fujiwara Y, Schulick RD.
Surg Today. 2020 Oct;50(10):1117-1125. doi: 10.1007/s00595-020-02028-0. Epub 2020 May 30.
Adjuvant Chemotherapy.
Hellyer JA, Wakelee HA.
Thorac Surg Clin. 2020 May;30(2):179-185. doi: 10.1016/j.thorsurg.2020.01.003. Epub 2020 Mar 2.
Uterine Adenosarcoma.
Ulrich UA, Denschlag D.
Oncol Res Treat. 2018;41(11):693-696. doi: 10.1159/000494067. Epub 2018 Oct 17.
Malignant tumor overview.
Reardon MJ.
Methodist Debakey Cardiovasc J. 2010 Jul-Sep;6(3):35-7. doi: 10.14797/mdcj-6-3-35.
The development of dose-dense adjuvant chemotherapy.
Hudis C, Dang C.
Breast J. 2015 Jan-Feb;21(1):42-51. doi: 10.1111/tbj.12364. Epub 2014 Dec 22.
Adjuvant chemotherapy could improve the survival of pulmonary sarcomatoid carcinoma: A systematic review and meta-analysis.
Zombori-Tóth N, Kiss S, Oštarijaš E, Alizadeh H, Zombori T.
Surg Oncol. 2022 Sep;44:101824. doi: 10.1016/j.suronc.2022.101824. Epub 2022 Jul 31.
Differences in the performance of adjuvant chemotherapy between hemodialysis and nonhemodialysis patients.
Ishii T, Watanabe T, Higashi T.
Cancer Med. 2023 Feb;12(4):4033-4041. doi: 10.1002/cam4.5258. Epub 2022 Sep 21.
Splenic stromal sarcomas in dogs: Outcome and clinicopathological prognostic factors in 32 cases.
Ferrari R, Marconato L, Boracchi P, Stefanello D, Godizzi F, Murgia D, Schievenin V, Amati M, Faroni E, Roccabianca P.
Vet Comp Oncol. 2024 Mar;22(1):12-21. doi: 10.1111/vco.12941. Epub 2023 Nov 2.
Effects of adjuvant chemotherapy on recurrence rate in T1abN0M0 triple-negative breast cancer: A meta-analysis.
Yang Z, Chen Y, Liu X, Cui J, Hu Y, Wei W.
Cancer Treat Res Commun. 2020;25:100211. doi: 10.1016/j.ctarc.2020.100211. Epub 2020 Sep 19.
